Page last updated: 2024-09-04

pomalidomide and Lymphopenia

pomalidomide has been researched along with Lymphopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baird, K; Berger, A; Cao, L; Comis, LE; Cowen, EW; Curtis, LM; Figg, WD; Gale, RP; Hakim, FT; Holtzman, NG; Joe, GO; Kuzmina, ZJ; Mays, JW; Mitchell, SA; Ostojic, A; Parsons-Wandell, L; Pavletic, SZ; Peer, CJ; Pirsl, F; Pusic, I; Rose, JJ; Venzon, DJ	1

Trials

1 trial(s) available for pomalidomide and Lymphopenia

Article	Year
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease. Blood, 2021, 02-18, Volume: 137, Issue:7 Topics: Adolescent; Adult; Aged; Allografts; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance; Fatigue; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Infections; Joints; Kaplan-Meier Estimate; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Middle Aged; Quality of Life; Salvage Therapy; Skin; Thalidomide; Young Adult	2021

Article

Year

A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.

Blood, 2021, 02-18, Volume: 137, Issue:7

Topics: Adolescent; Adult; Aged; Allografts; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance; Fatigue; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Infections; Joints; Kaplan-Meier Estimate; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Middle Aged; Quality of Life; Salvage Therapy; Skin; Thalidomide; Young Adult

2021